Birmingham/Oxford, 20 July 2012. Mercia Fund Management has launched the Mercia Growth Fund capitalising on the recent introduction of Seed EIS (SEIS) and the marked enhancements to EIS in the Finance Act. Mercia Fund Management believes a hybrid fund will provide investors with a combination of maximised tax efficiency and the flexibility to invest in
PRESS RELEASE FOR IMMEDIATE RELEASE PolyTherics granted further patents for TheraPEG™ and GlycoPol™ POLYTHERICS EXPANDS THE COVERAGE OF ITS PATENTS IN MAJOR MARKETS London, UK, 18th June 2012 – PolyTherics Limited (“PolyTherics”), a provider of solutions to enable the development of better biopharmaceuticals, has strengthened its intellectual property estate with the granting of further patents
Champaign, Illinois, 2012-05-14 – The Blue Waters project is now well underway with a completion date of Fall 2012. As one of the most powerful supercomputers in the world, its immense computational power and stability will allow scientists to make breakthroughs in a diverse range of fields. Allinea DDT is the debugger they call on
Pro Bono Bio and PolyTherics progress and expand their relationship for the development of improved blood factors London, UK, 29 May 2012 – Pro Bono Bio Group plc (“PBB”), the international healthcare group, and PolyTherics Limited (“PolyTherics”), a provider of solutions for the development of better biopharmaceuticals, announce progress on their haematology alliance to produce
ENHANCED BREADTH OF EXPERIENCE ON POLYTHERICS’ BOARD SUPPORTS NEXT PHASE OF DEVELOPMENT London, UK, 15 May 2012 – Mark Payton of Mercia Fund Management, a founding investor in Warwick Effect Polymers (which was acquired by Polytherics in January 2012), and a director of Polytherics Limited (“PolyTherics”), a provider of solutions to enable the development of
MIAMI, May 10, 2012 (GlobeNewswire via COMTEX) — Internal Fixation Systems (otcqb:IFIX) announced today that it has entered into a distribution agreement with Intelligent Orthopaedics Ltd. (IO) to market its Staffordshire Orthopaedic Reduction Machine (STORM) which is a reusable device that is used to reduce (align) fractures of the tibia prior to surgical fixation. IO
NewNet Investor Profile of Andrew Oldfield Head of Clean Tech at Mercia Fund Management (subscription required) – http://www.newenergyworldnetwork.com/investor-news/clean-energy-investor-profiles/newnet-investor-profile-andrew-oldfield-mercia-fund-management.html Ben Samuel from NewNetEnergyNetwork spoke to Andrew Oldfield to discover Mercia Fund Management’s plans to invest in cleantech companies, which are looking for moderate capital needs and are focused on efficiency. In the interview Andrew highlights portfolio
Mark Payton was recently interviewed by Alec Macfarlane of AltAssets. Here is an excerpt from the article below. To read the full article here. http://www.altassets.net/private-equity-news/by-pe-sector/venturegrowth/smaller-investors-british-smes-set-to-capitalise-on-eis-provisions.htmlSmaller investors, British SMEs set to capitalise on EIS provisionsThe UK’s new Finance Bill has divided the UK private equity space, and is expected to put an end to management buy-outs
STORM is a reusable surgical device that is used in the operating theatre to provide the surgeon with a simple but innovative approach to reducing challenging unstable lower limb fractures prior to fixation. STORM provides precise and controllable axial traction; a simple lock wheel system allows large and fine adjustments to correct rotation and the
Capital growth is seen as a key element for economic recovery and the coalition government has boosted schemes such as the Enterprise Investment Scheme (EIS) and Seed EIS (SEIS) to unprecedented levels. What is required, however, is some clarity on what the benefits of EIS investing are, direct investing or via a fund, approved or